Back to Search
Start Over
Acute teriflunomide overdose with relatively mild symptoms: A case report.
- Source :
-
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2021 Dec; Vol. 46 (6), pp. 1784-1786. Date of Electronic Publication: 2021 Jan 09. - Publication Year :
- 2021
-
Abstract
- What Is Know and Objective: Teriflunomide is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis.<br />Case Summary: We present a rare intoxication with a high dose (672 mg) of teriflunomide. According to its product label, the only known treatment is the administration of colestyramine and activated carbon (charcoal). No serious adverse events occurred during the time the patient was admitted (<24 h). No long-term overdose-related symptoms or complaints were reported.<br />What Is New and Conclusion: The fact that after the acute overdose both adverse events and laboratory parameters were acceptable, prescribing colestyramine and activated carbon, as well as monitoring of laboratory parameters such as full blood count, liver and kidney values and QTc, seems sufficient during the early stage (<24 h after intake) of teriflunomide overdose.<br /> (© 2021 John Wiley & Sons Ltd.)
- Subjects :
- Adult
Antidotes therapeutic use
Charcoal therapeutic use
Cholestyramine Resin therapeutic use
Drug Overdose drug therapy
Humans
Male
Anti-Inflammatory Agents, Non-Steroidal toxicity
Crotonates toxicity
Drug Overdose physiopathology
Hydroxybutyrates toxicity
Nitriles toxicity
Toluidines toxicity
Subjects
Details
- Language :
- English
- ISSN :
- 1365-2710
- Volume :
- 46
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Journal of clinical pharmacy and therapeutics
- Publication Type :
- Report
- Accession number :
- 33421160
- Full Text :
- https://doi.org/10.1111/jcpt.13360